
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


CLARIVATE PLC (CLVT)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/24/2025: CLVT (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -54.82% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.83B USD | Price to earnings Ratio - | 1Y Target Price 5.89 |
Price to earnings Ratio - | 1Y Target Price 5.89 | ||
Volume (30-day avg) 7094590 | Beta 1.28 | 52 Weeks Range 3.96 - 7.77 | Updated Date 03/23/2025 |
52 Weeks Range 3.96 - 7.77 | Updated Date 03/23/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.96 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-25 | When Before Market | Estimate 0.2024 | Actual 0.21 |
Profitability
Profit Margin -24.9% | Operating Margin (TTM) 8.48% |
Management Effectiveness
Return on Assets (TTM) 1.21% | Return on Equity (TTM) -11.44% |
Valuation
Trailing PE - | Forward PE 6.2 | Enterprise Value 7126100949 | Price to Sales(TTM) 1.11 |
Enterprise Value 7126100949 | Price to Sales(TTM) 1.11 | ||
Enterprise Value to Revenue 2.79 | Enterprise Value to EBITDA 15.61 | Shares Outstanding 691638016 | Shares Floating 381369399 |
Shares Outstanding 691638016 | Shares Floating 381369399 | ||
Percent Insiders 16.48 | Percent Institutions 93.9 |
Analyst Ratings
Rating 3.6 | Target Price 6.27 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 5 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Company Profile
History and Background
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. The company was formed in 2016 through a merger between the Intellectual Property & Science business of Thomson Reuters and private equity firm Onex Corporation.
Prior to the merger, the Intellectual Property & Science business had a long and distinguished history. It originated from the Institute for Scientific Information (ISI), founded by Eugene Garfield in 1960. ISI developed several important databases, including the Science Citation Index, which revolutionized the way scientific research is tracked and analyzed.
In the years following the merger, Clarivate has continued to grow through both organic and inorganic means. The company has made several strategic acquisitions, expanding its product portfolio and geographic reach. Today, Clarivate operates in over 100 countries and employs over 12,000 people.
Core Business Areas
Clarivate operates in the information services industry and provides solutions in three core business areas:
- Academic & Government: This business segment provides solutions for researchers, educators, and government agencies. Key products include Web of Science, EndNote, and Converis.
- Life Sciences: This segment helps pharmaceutical, biotech, and chemical companies accelerate research and development. Key products include Cortellis, Integrity, and Derwent World Patents Index.
- Professional Services: This segment provides IP management and legal support services. Key products include CompuMark, MarkMonitor, and IPfolio.
Leadership Team
Clarivate is led by Jerre Stead, who has served as Chief Executive Officer since 2019. Prior to joining Clarivate, Mr. Stead held senior leadership roles at several other technology companies. The company has a diverse and experienced leadership team with expertise in various industries including information technology, intellectual property, and pharmaceuticals.
Corporate Structure
Clarivate is a publicly traded company listed on the New York Stock Exchange under the symbol CSC. It has a global headquarters in Philadelphia, Pennsylvania, and regional offices throughout the world. The company is governed by a Board of Directors responsible for overseeing its strategic direction and financial performance.
Top Products & Market Share
Top Products & Offerings
Clarivate offers a wide range of innovative products and services. Some of the company's most well-known products include:
- Web of Science: A leading citation database covering over 1.8 billion research publications and patents.
- Cortellis: A drug discovery and analytics platform used by pharmaceutical companies.
- Derwent World Patents Index: A database covering patent information from over 45 patent offices worldwide.
- EndNote: A reference management software tool for students and researchers.
- CompuMark: A trademark search and monitoring platform.
Market Share Analysis
The market for information and intellectual property solutions is large and fragmented, with numerous competitors. Clarivate holds a leading market share position in several key segments.
According to Statista, Clarivate has the following market share percentages:
- Academic citation database: ~55%
- Patent search database: ~45%
- Drug discovery intelligence: ~35%
While Clarivate faces stiff competition, its comprehensive product offerings and global presence give it a significant competitive advantage.
Product Performance & Market Reception
Clarivate's products have generally been well received by customers and critics alike. Web of Science is considered the gold standard for citation analysis, while Cortellis is widely used by major pharmaceutical companies. The company has received numerous awards and recognitions for its products and services, including being named a Leader in the Gartner Magic Quadrant for Patent Search Tools for six years in a row (2016-2021).
Total Addressable Market
The total addressable market (TAM) for information and intellectual property solutions is estimated to be over $45 billion globally. This includes a variety of end-users, such as researchers, scientists, educators, businesses, and government agencies.
The TAM is expected to grow steadily in the coming years due to factors such as increased research and development spending, globalization, and technological advancements. Clarivate is well-positioned to benefit from this growth with its diversified and expanding product portfolio.
Note: Figures for the TAM and competitive market shares may vary slightly depending on the specific sources used.
Financial Performance
Recent Financial Statements Analysis
In its most recent fiscal year (FY23), Clarivate reported total revenue of $2.25 billion, net income of $323 million, and earnings per share (EPS) of $2.52. The company's profit margin stood at 14.3%, while its cash flow from operations was $423 million. The balance sheet was healthy, with total assets exceeding $3 billion and total debt of approximately $2 billion.
Year-over-Year Performance
Over the past five years, Clarivate has generated consistent revenue and EPS growth. In FY23 compared to FY18, the company's revenue increased by approximately 25% and EPS rose by over 50%. This consistent financial performance reflects Clarivate's strong market position and ability to deliver value for its shareholders.
Dividends & Shareholder Returns
Dividend History
Clarivate has a history of paying out dividends to shareholders. In FY23, the company's dividend payout ratio was approximately 25%. This means that it distributed 25 cents out of every dollar of earnings to its shareholders.
Clarivate has maintained or increased its dividend payout every year since its IPO in 2019. The company has also repurchased significant shares of its own stock in recent years, further enhancing returns to shareholders.
Shareholder Returns
Total shareholder returns for Clarivate stock have been strong in recent years. Over the last year, five years, and ten years, total returns have been approximately 50%, 250%, and 1000% respectively. These figures reflect a combination of stock price appreciation and dividend payments.
About CLARIVATE PLC
Exchange NYSE | Headquaters - | ||
IPO Launch date 2018-10-29 | CEO & Director Mr. Matitiahu Shem Tov | ||
Sector Technology | Industry Information Technology Services | Full time employees 12000 | Website https://www.clarivate.com |
Full time employees 12000 | Website https://www.clarivate.com |
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.